Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Shares Issued (2016 - 2025)

Orthofix Medical (OFIX) has disclosed Shares Issued for 16 consecutive years, with $2.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Issued fell 3.63% year-over-year to $2.8 million, compared with a TTM value of $5.9 million through Dec 2025, up 1.94%, and an annual FY2025 reading of $5.9 million, down 5.24% over the prior year.
  • Shares Issued was $2.8 million for Q4 2025 at Orthofix Medical, up from $36000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $3.0 million in Q2 2025 and bottomed at $36000.0 in Q3 2025.
  • Average Shares Issued over 5 years is $1.9 million, with a median of $2.3 million recorded in 2021.
  • The sharpest move saw Shares Issued surged 81.12% in 2021, then plummeted 70.0% in 2025.
  • Year by year, Shares Issued stood at $2.6 million in 2021, then fell by 25.1% to $1.9 million in 2022, then skyrocketed by 41.97% to $2.8 million in 2023, then grew by 7.13% to $2.9 million in 2024, then dropped by 3.63% to $2.8 million in 2025.
  • Business Quant data shows Shares Issued for OFIX at $2.8 million in Q4 2025, $36000.0 in Q3 2025, and $3.0 million in Q2 2025.